127 related articles for article (PubMed ID: 10785556)
1. Protease inhibitors - part 5. Alkyl/arylsulfonyl- and arylsulfonylureido-/arylureido- glycine hydroxamate inhibitors of Clostridium histolyticum collagenase.
Scozzafava A; Supuran CT
Eur J Med Chem; 2000 Mar; 35(3):299-307. PubMed ID: 10785556
[TBL] [Abstract][Full Text] [Related]
2. Protease inhibitors. Part 7. Inhibition of Clostridium histolyticum collagenase with sulfonylated derivatives of L-valine hydroxamate.
Supuran CT; Scozzafava A
Eur J Pharm Sci; 2000 Mar; 10(1):67-76. PubMed ID: 10699384
[TBL] [Abstract][Full Text] [Related]
3. Protease inhibitors. Part 8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated L-alanine hydroxamate moieties.
Scozzafava A; Supuran CT
Bioorg Med Chem; 2000 Mar; 8(3):637-45. PubMed ID: 10732980
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors: Synthesis of L-alanine hydroxamate sulfonylated derivatives as inhibitors of clostridium histolyticum collagenase.
Supuran CT; Briganti F; Mincione G; Scozzafava A
J Enzyme Inhib; 2000; 15(2):111-28. PubMed ID: 10938538
[TBL] [Abstract][Full Text] [Related]
5. Protease inhibitors: synthesis of potent bacterial collagenase and matrix metalloproteinase inhibitors incorporating N-4-nitrobenzylsulfonylglycine hydroxamate moieties.
Scozzafava A; Supuran CT
J Med Chem; 2000 May; 43(9):1858-65. PubMed ID: 10794702
[TBL] [Abstract][Full Text] [Related]
6. Protease inhibitors. Part 12. Synthesis of potent matrix metalloproteinase and bacterial collagenase inhibitors incorporating sulfonylated N-4-nitrobenzyl-beta-alanine hydroxamate moieties.
Scozzafava A; Ilies MA; Manole G; Supuran CT
Eur J Pharm Sci; 2000 Jul; 11(1):69-79. PubMed ID: 10913755
[TBL] [Abstract][Full Text] [Related]
7. Protease inhibitors: synthesis of clostridium histolyticum collagenase inhibitors incorporating sulfonyl-L-alanine hydroxamate moieties.
Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2000 Mar; 10(5):499-502. PubMed ID: 10743957
[TBL] [Abstract][Full Text] [Related]
8. Protease inhibitors: synthesis of a series of bacterial collagenase inhibitors of the sulfonyl amino acyl hydroxamate type.
Clare BW; Scozzafava A; Supuran CT
J Med Chem; 2001 Jun; 44(13):2253-8. PubMed ID: 11405662
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating arylsulfonylureido and 5-dibenzo-suberenyl/suberyl moieties.
Ilies M; Banciu MD; Scozzafava A; Ilies MA; Caproiu MT; Supuran CT
Bioorg Med Chem; 2003 May; 11(10):2227-39. PubMed ID: 12713832
[TBL] [Abstract][Full Text] [Related]
10. Protease inhibitors: synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions.
Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2002 Oct; 12(19):2667-72. PubMed ID: 12217351
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase and matrix metalloproteinase inhibitors: sulfonylated amino acid hydroxamates with MMP inhibitory properties act as efficient inhibitors of CA isozymes I, II, and IV, and N-hydroxysulfonamides inhibit both these zinc enzymes.
Scozzafava A; Supuran CT
J Med Chem; 2000 Oct; 43(20):3677-87. PubMed ID: 11020282
[TBL] [Abstract][Full Text] [Related]
12. Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating succinyl hydroxamate and iminodiacetic acid hydroxamate moieties.
Santos MA; Marques S; Gil M; Tegoni M; Scozzafava A; Supuran CT
J Enzyme Inhib Med Chem; 2003 Jun; 18(3):233-42. PubMed ID: 14506914
[TBL] [Abstract][Full Text] [Related]
13. N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.
Hanessian S; Moitessier N; Gauchet C; Viau M
J Med Chem; 2001 Sep; 44(19):3066-73. PubMed ID: 11543675
[TBL] [Abstract][Full Text] [Related]
14. A quantitative structure-activity relationship study on Clostridium histolyticum collagenase inhibitors: roles of electrotopological state indices.
Gupta SP; Kumaran S
Bioorg Med Chem; 2003 Jul; 11(14):3065-71. PubMed ID: 12818668
[TBL] [Abstract][Full Text] [Related]
15. Peptide hydroxamic acids inhibit skin collagenase.
Moore WM; Spilburg CA
Biochem Biophys Res Commun; 1986 Apr; 136(1):390-5. PubMed ID: 3010973
[TBL] [Abstract][Full Text] [Related]
16. A quantitative structure-activity relationship study on some matrix metalloproteinase and collagenase inhibitors.
Kumar D; Gupta SP
Bioorg Med Chem; 2003 Feb; 11(3):421-6. PubMed ID: 12517437
[TBL] [Abstract][Full Text] [Related]
17. The design and synthesis of aryl hydroxamic acid inhibitors of MMPs and TACE.
Levin JI
Curr Top Med Chem; 2004; 4(12):1289-310. PubMed ID: 15320727
[TBL] [Abstract][Full Text] [Related]
18. A comparative QSAR study on carbonic anhydrase and matrix metalloproteinase inhibition by sulfonylated amino acid hydroxamates.
Gupta SP; Maheswaran V; Pande V; Kumar D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):7-13. PubMed ID: 12751815
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.
Pikul S; McDow Dunham KL; Almstead NG; De B; Natchus MG; Anastasio MV; McPhail SJ; Snider CE; Taiwo YO; Chen L; Dunaway CM; Gu F; Mieling GE
J Med Chem; 1999 Jan; 42(1):87-94. PubMed ID: 9888835
[TBL] [Abstract][Full Text] [Related]
20. N-alkyl urea hydroxamic acids as a new class of peptide deformylase inhibitors with antibacterial activity.
Hackbarth CJ; Chen DZ; Lewis JG; Clark K; Mangold JB; Cramer JA; Margolis PS; Wang W; Koehn J; Wu C; Lopez S; Withers G; Gu H; Dunn E; Kulathila R; Pan SH; Porter WL; Jacobs J; Trias J; Patel DV; Weidmann B; White RJ; Yuan Z
Antimicrob Agents Chemother; 2002 Sep; 46(9):2752-64. PubMed ID: 12183225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
